Two strains of polio are gone, but the end of the disease is still far off

In another milestone on the long, expensive and sometimes discouraging road to wiping out polio, global health officials announced Wednesday that two of the three strains of wild polio virus have officially been eliminated.

>> Donald G McNeil JrThe New York Times
Published : 24 Oct 2019, 09:16 AM
Updated : 24 Oct 2019, 09:16 AM

Although that brings the world another step closer to eradication, the effort has taken far longer than was ever anticipated. When the campaign began in 1988, most public health officials and donors expected the battle to be over by 2000.

But two major obstacles emerged.

First, millions of families around the world have not let their children have the drops because of persistent false rumours that the vaccine is a Western plot to sterilise Muslim girls or do other harm.

Second, in some countries viruses used in the oral vaccine itself have mutated into a form that can be passed on in diapers and sewage, and can paralyse unvaccinated children. That has contributed to fear of the oral vaccine, even though full vaccination is the only protection against such mutant viruses.

Just in the last two months, cases of paralysis caused by mutant vaccine viruses have been reported in the Philippines, Zambia, Togo and Chad. Because paralysis occurs in only about 1 in every 200 cases of polio, experts assume many more children have been infected.

Stopping such outbreaks typically requires vaccinating hundreds of thousands of children with both the injectable vaccine, which contains killed virus that cannot mutate, and the oral vaccine. The latter contains weakened viruses that normally cannot cause disease but provide better protection than killed viruses.

The strain that the Global Certification Commission for the Eradication of Poliovirus declared eliminated this week is Type 3 wild polio virus, the last case of which was seen in Nigeria in 2012. Type 2 was declared eliminated in 2015; the last case was detected in India in 1999.

Type 1, the only wild strain left, circulates only in Pakistan and Afghanistan.

(In the 1950s, the three strains had more evocative names: Brunhilde, Lansing and Leon. The first was named after a lab chimpanzee, the second after the Michigan city where it was isolated, and the third after a Los Angeles boy who died of it. The nicknames later fell out of favour.)

Enormous, multiyear surveillance efforts are required before a viral strain can be declared extinct. Children can be paralysed by several other viruses, by bacterial brain infections and by neck and spine injuries.

To ensure that polio was not the cause, stool samples must be taken from more than 100,000 paralysed children every year. Thousands of sewage and water samples are drawn in 70 countries; the virus can be detected at parts-per-million concentrations.

“The certification commission has been very, very careful,” said Dr Walter A Orenstein, a polio expert at Emory Vaccine Centre in Atlanta and former immunisation director at the Centres for Disease Control and Prevention.

In the last decade, a dangerous new front has opened in the war on polio.

In countries where vaccination rates are low, the weakened viruses in the oral vaccine can circulate in wastewater and mutate into what are effectively evil twins of themselves.

By piling up random genetic changes, or by swapping genes with other intestinal viruses like Coxsackie virus, viruses can become virulent again and paralyse children who have never been vaccinated.

In the last two years, outbreaks of cVDPV — which stands for “circulating vaccine-derived polio virus” — have struck nearly 20 countries.

Although most of those outbreaks have been small and eventually were contained, more children are now paralysed by cVDPV each year than by Type 1 in Pakistan and Afghanistan.

For example, thus far this year, 88 Pakistani and Afghani children have been paralysed by the last wild strain, while 95 children in Africa and Asia have been paralysed by vaccine-derived viruses.

To prevent that, the eradication campaign is taking several steps.

First, health officials are trying to see that every child in the world gets at least one dose of the injected vaccine. It circulates in the blood, so a child can still get — and spread — a gut infection but won’t be paralysed by it.

Second, a year after Type 2 polio was eliminated worldwide, the campaign rolled out a new “bivalent” vaccine lacking the Type 2 weakened virus.

But there will be no “monovalent” vaccine with only Type 1 weakened virus, said Michel Zaffran, director of polio eradication at the World Health Organisation.

“The Type 2 was so powerful that it dominated the old vaccine,” he said. “Removing Type 3 will not make the current one more immunogenic.”

It was a bureaucratic nightmare, he added, to get every country in the world to import and refrigerate hundreds of millions of new vaccine doses and safely destroy their old ones.

“We don’t need to create a new problem,” Zaffran said.

Third, the Bill and Melinda Gates Foundation is supporting the creation of new oral vaccines less able to mutate into dangerous forms.

“Tightening the loose ends” by cutting some nucleotides out of the part of the genome that acts as a gatekeeper leaves it less likely to swap genes with other gut viruses, said Dr Ananda S Bandyopadhyay, a polio programme officer at the foundation.

In addition, rearranging the genes that create the polymerase, which helps the virus copy itself, means fewer “copying errors” that may be dangerous.

Because most recent outbreaks have been caused by mutant versions of Type 2, the foundation has fast-tracked clinical trials on that strain of the new vaccine, Bandyopadhyay said.

“If all goes well, it could be ready as early as 2020,” he said.

Novel versions of Type 1 and Type 3 vaccines should follow in another couple of years, he said.

The new versions are not intended for routine vaccination, he said, but for an emergency stockpile used to fight outbreaks.

© 2019 New York Times News Service